((Chlorodifluoromethyl)sulfonyl)benzene, 95+%, 250mg

1H-Indazol-6-amine, 95.0%, 500g

Einkanal-Mikroliterpipette ROTILABO®, 500 bis 5000 µl, 1 Stück

3-METHYLIMIDAZOLIDIN-4-ONE HCL, 95%, 1g

3-[[(1S,2S)-2-(1-Piperidinyl)cyclohexyl]amino]-4-[[4-(trifluoromethyl)phenyl]amino]-3-cyclobutene-1,2-dione, 97%, 50mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 20 m, Ø-Innen 0,10 mm, Filmd. 0,40 µm, 1 Stück

Rotilabo®-Spritzenfilter, CME, steril, Porengröße 0,45 µm, Ø 15 mm, 100 Stück

2-Amino-5-chlorobenzonitrile, 97.0%, 5g

Benzo[c]isothiazole-4-carboxylic acid, 95.0%, 250mg

ETHYL 2-(PYRIDIN-4-YL)PYRIMIDINE-5-CARBOXYLATE, 95%, 100mg

2-Hydroxy-6-methylnicotinic Acid>98.0%(GC)(T)25g

1-Amino-2-methylnaphthalene, 98.0%, 25g

3,5-dibromo-1-[(2,4,5-trifluorophenyl)methyl]-1H-1,2,4-triazole, 95.0%, 1g